Bioceltix S.A. XI3.F Stock
Bioceltix S.A. Price Chart
Bioceltix S.A. XI3.F Financial and Trading Overview
| Bioceltix S.A. stock price | 12.82 EUR |
| Previous Close | 13.55 EUR |
| Open | 13.65 EUR |
| Bid | 14.15 EUR x N/A |
| Ask | 15.5 EUR x N/A |
| Day's Range | 13.65 - 13.65 EUR |
| 52 Week Range | 6.06 - 16.45 EUR |
| Volume | 10 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 51.11M EUR |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.87 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
XI3.F Valuation Measures
| Enterprise Value | 53.92M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Bioceltix S.A. Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 87.67% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 16.45 EUR |
| 52 Week Low | 6.06 EUR |
| 50-Day Moving Average | 13.17 EUR |
| 200-Day Moving Average | 9.2 EUR |
XI3.F Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 3.58M |
| Float | 2.47M |
| Short Ratio | N/A |
| % Held by Insiders | 47.50% |
| % Held by Institutions | 4.31% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -70.62% |
| Return on Equity (ttm) | -160.016% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.65 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | 5.71 EUR |
| Current Ratio (mrq) | 2.68 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Bioceltix S.A.
| Country | Germany |
| State | N/A |
| City | Wroclaw |
| Address | Building III |
| ZIP | 51-317 |
| Phone | 48 71 880 8771 |
| Website | https://bioceltix.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 20 |
Bioceltix S.A. engages in the development of stem cell-based biopharmaceuticals for veterinary use. Its products include BCX-CM-J, a stem-cell based biological drug for the treatment of degenerative joint lesions in dogs; BCX-CM-AD, a biological drug candidate based on allogeneic stem cells for the treatment of atopic dermatitis in dogs; and BCX-EM, a biological drug candidate based on allogeneic mesenchymal stem cells for the treatment of arthritis in horses. The company was incorporated in 2018 and is based in Wroclaw, Poland.
Q&A For Bioceltix S.A. Stock
What is a current XI3.F stock price?
Bioceltix S.A. XI3.F stock price today per share is 12.82 EUR.
How to purchase Bioceltix S.A. stock?
You can buy XI3.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Bioceltix S.A.?
The stock symbol or ticker of Bioceltix S.A. is XI3.F.
Which industry does the Bioceltix S.A. company belong to?
The Bioceltix S.A. industry is Biotechnology.
How many shares does Bioceltix S.A. have in circulation?
The max supply of Bioceltix S.A. shares is 5.82M.
What is Bioceltix S.A. Price to Earnings Ratio (PE Ratio)?
Bioceltix S.A. PE Ratio is now.
What was Bioceltix S.A. earnings per share over the trailing 12 months (TTM)?
Bioceltix S.A. EPS is -0.87 EUR over the trailing 12 months.
Which sector does the Bioceltix S.A. company belong to?
The Bioceltix S.A. sector is Healthcare.